These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17146463)

  • 21. Imbalanced production of cytokines by T cells associates with the activation/exhaustion status of memory T cells in chronic HIV type 1 infection.
    Nakayama K; Nakamura H; Koga M; Koibuchi T; Fujii T; Miura T; Iwamoto A; Kawana-Tachikawa A
    AIDS Res Hum Retroviruses; 2012 Jul; 28(7):702-14. PubMed ID: 21902582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Naïve T-cell dynamics in human immunodeficiency virus type 1 infection: effects of highly active antiretroviral therapy provide insights into the mechanisms of naive T-cell depletion.
    Di Mascio M; Sereti I; Matthews LT; Natarajan V; Adelsberger J; Lempicki R; Yoder C; Jones E; Chow C; Metcalf JA; Sidorov IA; Dimitrov DS; Polis MA; Kovacs JA
    J Virol; 2006 Mar; 80(6):2665-74. PubMed ID: 16501076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous activation of viral antigen-specific memory CD4+ and CD8+ T-cells using mRNA-electroporated CD40-activated autologous B-cells.
    Van den Bosch GA; Van Gulck E; Ponsaerts P; Nijs G; Lenjou M; Apers L; Kint I; Heyndrickx L; Vanham G; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
    J Immunother; 2006; 29(5):512-23. PubMed ID: 16971807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Control of HIV-1 Pathogenesis in Viremic Nonprogressors Is Independent of Gag-Specific Cytotoxic T Lymphocyte Responses.
    Salgado M; Garcia-Minambres A; Dalmau J; Jiménez-Moyano E; Viciana P; Alejos B; Clotet B; Prado JG; Martinez-Picado J
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Presence of human immunodeficiency virus-1-specific CD4 and CD8 cellular immune responses in children with full or partial virus suppression.
    Papasavvas E; Sandberg JK; Rutstein R; Moore EC; Mackiewicz A; Thiel B; Pistilli M; June RR; Jordan KA; Gross R; Maino VC; Nixon DF; Montaner LJ
    J Infect Dis; 2003 Sep; 188(6):873-82. PubMed ID: 12964119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of changes in antigen level on CD38/PD-1 co-expression on HIV-specific CD8 T cells in chronic, untreated HIV-1 infection.
    Vollbrecht T; Brackmann H; Henrich N; Roeling J; Seybold U; Bogner JR; Goebel FD; Draenert R
    J Med Virol; 2010 Mar; 82(3):358-70. PubMed ID: 20087935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential immunogenicity of HIV-1 clade C proteins in eliciting CD8+ and CD4+ cell responses.
    Ramduth D; Chetty P; Mngquandaniso NC; Nene N; Harlow JD; Honeyborne I; Ntumba N; Gappoo S; Henry C; Jeena P; Addo MM; Altfeld M; Brander C; Day C; Coovadia H; Kiepiela P; Goulder P; Walker B
    J Infect Dis; 2005 Nov; 192(9):1588-96. PubMed ID: 16206073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modelling the influence of activation-induced apoptosis of CD4+ and CD8+ T-cells on the immune system response of a HIV-infected patient.
    Stan GB; Belmudes F; Fonteneau R; Zeggwagh F; Lefebvre MA; Michelet C; Ernst D
    IET Syst Biol; 2008 Mar; 2(2):94-102. PubMed ID: 18397120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenotypic characterization of lymphocytes in HCV/HIV co-infected patients.
    Roe B; Coughlan S; Dean J; Lambert JS; Keating S; Norris S; Bergin C; Hall WW
    Viral Immunol; 2009 Feb; 22(1):39-48. PubMed ID: 19210227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reactivation Kinetics of HIV-1 and Susceptibility of Reactivated Latently Infected CD4+ T Cells to HIV-1-Specific CD8+ T Cells.
    Walker-Sperling VE; Cohen VJ; Tarwater PM; Blankson JN
    J Virol; 2015 Sep; 89(18):9631-8. PubMed ID: 26178987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV type 1 envelope glycoprotein 120 carboxy-terminal peptide-induced human T cell lines selectively suppress heterogeneous proliferative T cell responses to soluble antigens.
    Wilson SE; Habeshaw JA; Addawe MA; Hounsell EF; Oxford JS
    AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1313-24. PubMed ID: 9339848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infection of CD127+ (interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection.
    Zaunders JJ; Ip S; Munier ML; Kaufmann DE; Suzuki K; Brereton C; Sasson SC; Seddiki N; Koelsch K; Landay A; Grey P; Finlayson R; Kaldor J; Rosenberg ES; Walker BD; Fazekas de St Groth B; Cooper DA; Kelleher AD
    J Virol; 2006 Oct; 80(20):10162-72. PubMed ID: 17005693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamics of CD4+ T cells in HIV-1 infection.
    Ribeiro RM
    Immunol Cell Biol; 2007 Jun; 85(4):287-94. PubMed ID: 17389869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-CD95 (APO-1/Fas) autoantibodies and T cell depletion in human immunodeficiency virus type 1 (HIV-1)-infected children.
    Stricker K; Knipping E; Böhler T; Benner A; Krammer PH; Debatin KM
    Cell Death Differ; 1998 Mar; 5(3):222-30. PubMed ID: 10200468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PD-1 and its ligand PD-L1 are progressively up-regulated on CD4 and CD8 T-cells in HIV-2 infection irrespective of the presence of viremia.
    Tendeiro R; Foxall RB; Baptista AP; Pinto F; Soares RS; Cavaleiro R; Valadas E; Gomes P; Victorino RM; Sousa AE
    AIDS; 2012 Jun; 26(9):1065-71. PubMed ID: 22441249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status.
    Kinter AL; Hennessey M; Bell A; Kern S; Lin Y; Daucher M; Planta M; McGlaughlin M; Jackson R; Ziegler SF; Fauci AS
    J Exp Med; 2004 Aug; 200(3):331-43. PubMed ID: 15280419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell-to-Cell Spread of HIV and Viral Pathogenesis.
    Law KM; Satija N; Esposito AM; Chen BK
    Adv Virus Res; 2016; 95():43-85. PubMed ID: 27112280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular immune responses to HIV.
    McMichael AJ; Rowland-Jones SL
    Nature; 2001 Apr; 410(6831):980-7. PubMed ID: 11309628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The immune response to AIDS virus infection: good, bad, or both?
    Deeks SG; Walker BD
    J Clin Invest; 2004 Mar; 113(6):808-10. PubMed ID: 15067312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.